Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial

Abstract Background Fluoropyrimidines (FP) are the third most used chemotherapeutic drugs administered in solid tumors but have cardiotoxic side effects. We aimed to determine whether pre-chemotherapeutic cardiological assessment and management of cardiovascular risk factors could prevent FP-induced...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Johanne D. Lyhne, Vibeke B. Hansen, Lone D. Vestergaard, Susanne E. Hosbond, Martin Busk, Mayooran Gnanaganesh, Else Maae, Birgitte M. Havelund, Torben F. Hansen, Signe Timm, Lars H. Jensen, Mads D. Lyhne
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2025-05-01
Serie:	Cardio-Oncology
Ämnen:	Cardio-oncology Cardioprotection Coronary artery calcium score Adverse effects 5-FU Capecitabine
Länkar:	https://doi.org/10.1186/s40959-025-00344-3
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!